InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the full record of transactions filed by Aromando Andrew. Officer active across 1 company, notably Ambrx Biopharma, Inc.. In total, 1 filings have been recorded. Activity tracked since 11 December 2023. The latest transaction was disclosed on 11 December 2023 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration